United States securities and exchange commission logo





                 September 3, 2021

       James Garner
       Chief Executive Officer
       KAZIA THERAPEUTICS LTD
       Level 24, Three International Towers
       300 Barangaroo Avenue
       Sydney, NSW, 2000, Australia

                                                        Re: KAZIA THERAPEUTICS
LTD
                                                            Registration
Statement on Form F-3
                                                            Filed September 1,
2021
                                                            File No. 333-259224

       Dear Dr. Garner :

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

              Please contact Michael Davis at 202-551-4385 or Laura Crotty at
202-551-7614 with any
       questions.




                 Sincerely,


                 Division of Corporation Finance

                 Office of Life Sciences
       cc:                                              Andrew Reilly